NanoBase™ Rx: The Pharmacy Compounding Industry's Full Replacement for HLB Chemistry

NanoBase™ Rx: The Pharmacy Compounding Industry's Full Replacement for HLB Chemistry

NanoBase™ Rx is the first pharmacy compounding excipient to combine a tri-domain nano-delivery architecture with a lyotropic liquid crystal matrix. Engineered at Pensive Beauty Labs. The three engineered nano-domains (lipophilic, hydrophilic, interfacial bridging) are organized within a biomimetic lamellar and bicontinuous cubic liquid crystal phase structure that matches the native liquid crystalline lamellar organization of stratum corneum intercellular lipids. No other US compounding excipient productizes this combination. Excipient only. No API supplied.

Read More
Nanocosmetic Regulation in 2026: EU, FDA, and ISO Standards for Sub-Micron Delivery Systems
Nano-Delivery, Regulatory, Formulation Science Pensive Beauty Nano-Delivery, Regulatory, Formulation Science Pensive Beauty

Nanocosmetic Regulation in 2026: EU, FDA, and ISO Standards for Sub-Micron Delivery Systems

Regulatory framework for sub-micron cosmetic delivery in 2026. EU Cosmetics Regulation 1223/2009 nano notification, FDA voluntary nano guidance, and ISO 29701 and 80004 standards governing NanoBase™ and tri-domain nano-delivery platforms engineered by Pensive Beauty Labs.

Read More